Viewing nowCombinationPlus D Alendronate Tablets
Sodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 201403971 · Approved 2014.08.26 · Insurance code 649102430
Treatment of osteoporosis in postmenopausal women and men
Used for the treatment of osteoporosis in postmenopausal women and men.
Take 1 tablet of this medicine (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with plenty of water, at least 30 minutes before consuming any food, beverage, or other medication (see “General Precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The optimal duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data from 4 years. The need for continued treatment should be reassessed periodically in all patients receiving bisphosphonates. For patients at low risk of fracture, discontinuation should be considered after 3~5 years of treatment. Patients who discontinue treatment should be periodically reassessed for fracture risk. Other beverages or food, including mineral water and barley tea, and medications may reduce the absorption of alendronate (see “Interactions”). Consuming food within 30 minutes after taking this medicine or at the same time may reduce alendronate absorption in the body and decrease its effect. This medicine should be taken immediately after getting up in the morning and swallowed with plenty of water (170∼230 mL) to ensure rapid delivery to the stomach and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking this medicine and until after the first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see “Warnings” and “General Precautions”). Patients with inadequate dietary intake of calcium and vitamin D should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to Be Provided to Patients (4)). Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may require additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Once-weekly administration of 1 tablet of this medicine provides a week's supply of vitamin D at 400 IU or 800 IU per day. If a patient taking 1 tablet of this medicine forgets to take it on the scheduled day, take 1 tablet the next morning, resume taking it on the originally scheduled day, and then continue taking it regularly once weekly. However, do not take 2 tablets on the same day. Administration in elderly patients (65 years and older): No dosage adjustment is necessary. Administration in patients with renal impairment: No dosage adjustment is necessary for patients with mild to moderate renal impairment (creatinine clearance 35∼60 mL/min). However, use of this medicine is not recommended in patients with severe renal impairment (creatinine clearance less than 35 mL/min) because there is insufficient clinical experience.
Pediatric and adolescent patients (under 18 years of age): Safety and efficacy in pediatric and adolescent patients have not been established.
This medication may irritate the upper gastrointestinal mucosa, leading to esophagitis, esophageal ulcers, and esophageal erosion. If symptoms such as difficulty swallowing, pain during swallowing, pain behind the sternum, or heartburn occur during use, stop taking the medication and consult a physician immediately. Take this medication with a sufficient amount of water, and do not lie down for at least 30 minutes after taking it. Care must be taken to avoid going to bed immediately after taking it or forgetting the dosage. Patients with esophageal motility disorders, those who cannot sit or stand upright for more than 30 minutes, those allergic to any components in this drug, patients with hypocalcemia, and those with lactose intolerance should not take this medication. During use, gastrointestinal symptoms such as abdominal pain, nausea, dyspepsia, constipation, diarrhea, and gastric acid reflux may occur, and rarely, skin rashes or severe allergic reactions may occur. Serious side effects like osteonecrosis of the jaw have been reported rarely, so pay attention to oral hygiene; consult a physician if dental treatment is needed. This drug may interfere with the absorption of calcium supplements, antacids, and some medications, so a gap of more than 30 minutes should be maintained. During pregnancy, safety for the fetus has not been established; it should be used cautiously only when necessary, and caution is also required during lactation. It is not used in children, and elderly patients or those with severely impaired kidney function must follow a physician's guidance. In case of overdose, symptoms of hypocalcemia and gastrointestinal irritation may occur, so contact medical institutions immediately for appropriate treatment. Before taking this medication, carefully read the product instructions and follow the physician's guidance for the correct dosage and administration.
Esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, perforation, bleeding, dysphagia, odynophagia, pain behind the sternum, heartburn, abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid reflux, esophageal ulcer, vomiting, dysphagia, abdominal distension, gastritis, musculoskeletal (bone, muscle, or joint) pain, muscle cramps, headache, dizziness, dysgeusia, rash, erythema, anastomotic ulcer, urticaria, angioedema, myalgia, fatigue, asthenia, fever, symptoms of hypocalcemia, peripheral edema, oropharyngeal ulcer, gastric ulcer, duodenal ulcer, local jawbone necrosis, joint swelling, low-energy fractures of the femoral neck and other bones, dizziness, vertigo, itching, hair loss, Stevens-Johnson syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, cholesteatoma of the external auditory canal, adenoiditis
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a sealed container. Store at room temperature between 1 and 30 degrees Celsius away from direct light.
White to pale yellow rectangular tablets
4 tablets/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationSodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
Sodium Alendronate Hydrate · Cholecalciferol Concentrate Powder
Prescription medication · Combination
Korea Union Pharm Co., Ltd.
CombinationSodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
CombinationSodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationSodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationSodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Farm Gen Science Co., Ltd.
CombinationSodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.